Security key
00773U108
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)
CUSIP: 00773U108
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,163,711
- Total 13F shares
- 506,821
- Share change
- 0
- Total reported value
- $2,214,808
- Price per share
- $4.37
- Number of holders
- 1
Report period
Q1 2025
Institutions
1
Top holders
1
ADVM full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Adverum Biotechnologies, Inc. SEC filings
Adverum Biotechnologies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00773U108
Recent filing periods:
Top shareholders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC |
13D/G
|
— |
8.9%
|
1,871,482
|
— | $0 | 31 Mar 2025 | |
| Rush Ryan Bradford |
13D/G
|
— |
5.1%
|
1,050,000
|
$3,055,500 | $0 | 17 Dec 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
10%
|
2,268,064
|
$10,591,859 | — | 31 Dec 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
8.1%
|
1,796,482
|
$8,389,571 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
8%
|
1,760,056
|
$8,219,462 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
6.7%
|
1,485,282
|
$6,936,268 | — | 31 Dec 2024 | |
| Principia Wealth Advisory, LLC |
13F
|
Company |
6%
|
1,330,660
|
$6,214,181 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
4.8%
|
1,069,244
|
$4,993,369 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.7%
|
1,031,082
|
$4,815,154 | — | 31 Dec 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
2.5%
|
541,666
|
$2,529,580 | — | 31 Dec 2024 | |
| Versant Venture Management, LLC |
13F
|
Company |
2.3%
|
506,821
|
$2,366,854 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.3%
|
500,710
|
$2,338,316 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
442,490
|
$2,066,824 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
369,554
|
$1,725,817 | — | 31 Dec 2024 | |
| Pale Fire Capital SE |
13F
|
Company |
1.4%
|
315,154
|
$1,471,769 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
311,005
|
$1,452,413 | — | 31 Dec 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.3%
|
287,246
|
$1,341,439 | — | 31 Dec 2024 | |
| REGENERON PHARMACEUTICALS, INC. |
13F
|
Company |
0.82%
|
180,909
|
$844,845 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.78%
|
172,437
|
$805,280 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
152,577
|
$712,534 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.67%
|
149,071
|
$696,162 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.59%
|
129,605
|
$605,255 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.52%
|
114,788
|
$536,062 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.44%
|
98,027
|
$457,787 | — | 31 Dec 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.43%
|
95,997
|
$448,306 | — | 31 Dec 2024 | |
| Grant/GrossMendelsohn, LLC |
13F
|
Company |
0.38%
|
84,173
|
$393,088 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.27%
|
59,734
|
$278,958 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.26%
|
57,903
|
$270,407 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
48,335
|
$225,724 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.22%
|
47,614
|
$222,357 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
47,596
|
$222,273 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
43,576
|
$203,500 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
42,847
|
$200,095 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.18%
|
39,887
|
$186,272 | — | 31 Dec 2024 | |
| Corton Capital Inc. |
13F
|
Company |
0.15%
|
32,696
|
$152,690 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
31,667
|
$147,875 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.14%
|
30,664
|
$143,201 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.13%
|
28,266
|
$132,002 | — | 31 Dec 2024 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.12%
|
26,829
|
$125,291 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.09%
|
19,987
|
$93,339 | — | 31 Dec 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.08%
|
18,261
|
$85,279 | — | 31 Dec 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.07%
|
16,277
|
$76,014 | — | 31 Dec 2024 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.07%
|
15,446
|
$72,133 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
12,240
|
$57,161 | — | 31 Dec 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.05%
|
12,072
|
$56,376 | — | 31 Dec 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.05%
|
10,704
|
$48,703 | — | 31 Dec 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.05%
|
10,343
|
$48,302 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
4,362
|
$20,371 | — | 31 Dec 2024 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.02%
|
4,182
|
$19,530 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
3,556
|
$16,000 | — | 31 Dec 2024 |
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q1 2025
As of 31 Mar 2025,
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
506,821 shares.
The largest 1 holders included
Versant Venture Management, LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
1
Q1 2025 holders
1
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.